nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—PON1—hematologic cancer	0.388	0.9	CbGaD
Cefazolin—TPMT—Mercaptopurine—hematologic cancer	0.145	0.405	CbGbCtD
Cefazolin—ABCC4—Tioguanine—hematologic cancer	0.0851	0.238	CbGbCtD
Cefazolin—ALB—hematologic cancer	0.0432	0.1	CbGaD
Cefazolin—ABCC4—Mercaptopurine—hematologic cancer	0.0353	0.0989	CbGbCtD
Cefazolin—SLC22A8—Mercaptopurine—hematologic cancer	0.0221	0.0618	CbGbCtD
Cefazolin—ALB—Imatinib—hematologic cancer	0.013	0.0362	CbGbCtD
Cefazolin—SLC22A11—Methotrexate—hematologic cancer	0.0124	0.0347	CbGbCtD
Cefazolin—ABCC4—Methotrexate—hematologic cancer	0.0116	0.0323	CbGbCtD
Cefazolin—ALB—Prednisone—hematologic cancer	0.00854	0.0239	CbGbCtD
Cefazolin—ALB—Irinotecan—hematologic cancer	0.00809	0.0226	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—hematologic cancer	0.00722	0.0202	CbGbCtD
Cefazolin—PON1—hematopoietic system—hematologic cancer	0.0056	0.205	CbGeAlD
Cefazolin—SLC22A6—Methotrexate—hematologic cancer	0.00503	0.0141	CbGbCtD
Cefazolin—ALB—Methotrexate—hematologic cancer	0.00428	0.012	CbGbCtD
Cefazolin—PON1—blood—hematologic cancer	0.00371	0.136	CbGeAlD
Cefazolin—PON1—bone marrow—hematologic cancer	0.00359	0.131	CbGeAlD
Cefazolin—TPMT—hematopoietic system—hematologic cancer	0.0017	0.0623	CbGeAlD
Cefazolin—TPMT—gonad—hematologic cancer	0.0013	0.0474	CbGeAlD
Cefazolin—TPMT—blood—hematologic cancer	0.00113	0.0413	CbGeAlD
Cefazolin—TPMT—bone marrow—hematologic cancer	0.00109	0.04	CbGeAlD
Cefazolin—ABCC4—hematopoietic system—hematologic cancer	0.00102	0.0375	CbGeAlD
Cefazolin—SLC22A8—hematopoietic system—hematologic cancer	0.00102	0.0372	CbGeAlD
Cefazolin—TPMT—lung—hematologic cancer	0.00099	0.0362	CbGeAlD
Cefazolin—TPMT—testis—hematologic cancer	0.000934	0.0342	CbGeAlD
Cefazolin—ABCC4—blood—hematologic cancer	0.000678	0.0248	CbGeAlD
Cefazolin—TPMT—lymph node—hematologic cancer	0.000677	0.0248	CbGeAlD
Cefazolin—SLC22A8—blood—hematologic cancer	0.000673	0.0246	CbGeAlD
Cefazolin—ABCC4—bone marrow—hematologic cancer	0.000656	0.024	CbGeAlD
Cefazolin—ABCC4—lung—hematologic cancer	0.000595	0.0218	CbGeAlD
Cefazolin—ALB—testis—hematologic cancer	0.00058	0.0212	CbGeAlD
Cefazolin—ABCC4—testis—hematologic cancer	0.000561	0.0205	CbGeAlD
Cefazolin—ALB—lymph node—hematologic cancer	0.00042	0.0154	CbGeAlD
Cefazolin—ABCC4—lymph node—hematologic cancer	0.000407	0.0149	CbGeAlD
Cefazolin—Cefdinir—MPO—hematologic cancer	0.000203	0.224	CrCbGaD
Cefazolin—Cefotetan—ALB—hematologic cancer	0.00015	0.166	CrCbGaD
Cefazolin—Cefpiramide—ALB—hematologic cancer	0.000131	0.144	CrCbGaD
Cefazolin—Cefonicid—ALB—hematologic cancer	0.000114	0.126	CrCbGaD
Cefazolin—Cefmetazole—ALB—hematologic cancer	0.0001	0.111	CrCbGaD
Cefazolin—Cefoperazone—ALB—hematologic cancer	6.71e-05	0.0742	CrCbGaD
Cefazolin—Ceftriaxone—ALB—hematologic cancer	5.23e-05	0.0578	CrCbGaD
Cefazolin—Cefalotin—ALB—hematologic cancer	4.58e-05	0.0506	CrCbGaD
Cefazolin—Cephalexin—ALB—hematologic cancer	4.16e-05	0.046	CrCbGaD
Cefazolin—Shock—Dexamethasone—hematologic cancer	3.13e-05	0.000207	CcSEcCtD
Cefazolin—Shock—Betamethasone—hematologic cancer	3.13e-05	0.000207	CcSEcCtD
Cefazolin—Rash—Alitretinoin—hematologic cancer	3.12e-05	0.000206	CcSEcCtD
Cefazolin—Agitation—Prednisone—hematologic cancer	3.12e-05	0.000206	CcSEcCtD
Cefazolin—Dermatitis—Alitretinoin—hematologic cancer	3.12e-05	0.000206	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	3.11e-05	0.000206	CcSEcCtD
Cefazolin—Thrombocytopenia—Betamethasone—hematologic cancer	3.11e-05	0.000206	CcSEcCtD
Cefazolin—Thrombocytopenia—Dexamethasone—hematologic cancer	3.11e-05	0.000206	CcSEcCtD
Cefazolin—Vomiting—Ifosfamide—hematologic cancer	3.11e-05	0.000205	CcSEcCtD
Cefazolin—Hypersensitivity—Cisplatin—hematologic cancer	3.11e-05	0.000205	CcSEcCtD
Cefazolin—Headache—Alitretinoin—hematologic cancer	3.1e-05	0.000205	CcSEcCtD
Cefazolin—Diarrhoea—Gemcitabine—hematologic cancer	3.1e-05	0.000204	CcSEcCtD
Cefazolin—Nausea—Thalidomide—hematologic cancer	3.09e-05	0.000204	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—hematologic cancer	3.09e-05	0.000204	CcSEcCtD
Cefazolin—Dyspepsia—Triamcinolone—hematologic cancer	3.08e-05	0.000204	CcSEcCtD
Cefazolin—Rash—Ifosfamide—hematologic cancer	3.08e-05	0.000204	CcSEcCtD
Cefazolin—Dermatitis—Ifosfamide—hematologic cancer	3.08e-05	0.000203	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—hematologic cancer	3.08e-05	0.000203	CcSEcCtD
Cefazolin—Dizziness—Irinotecan—hematologic cancer	3.07e-05	0.000203	CcSEcCtD
Cefazolin—Urticaria—Etoposide—hematologic cancer	3.07e-05	0.000203	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—hematologic cancer	3.06e-05	0.000202	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—hematologic cancer	3.06e-05	0.000202	CcSEcCtD
Cefazolin—Abdominal pain—Etoposide—hematologic cancer	3.05e-05	0.000202	CcSEcCtD
Cefazolin—Body temperature increased—Etoposide—hematologic cancer	3.05e-05	0.000202	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—hematologic cancer	3.05e-05	0.000201	CcSEcCtD
Cefazolin—Hepatitis—Epirubicin—hematologic cancer	3.05e-05	0.000201	CcSEcCtD
Cefazolin—Syncope—Prednisone—hematologic cancer	3.04e-05	0.000201	CcSEcCtD
Cefazolin—Vomiting—Vincristine—hematologic cancer	3.03e-05	0.0002	CcSEcCtD
Cefazolin—Anorexia—Betamethasone—hematologic cancer	3.03e-05	0.0002	CcSEcCtD
Cefazolin—Anorexia—Dexamethasone—hematologic cancer	3.03e-05	0.0002	CcSEcCtD
Cefazolin—Urticaria—Prednisolone—hematologic cancer	3.03e-05	0.0002	CcSEcCtD
Cefazolin—Asthenia—Cisplatin—hematologic cancer	3.03e-05	0.0002	CcSEcCtD
Cefazolin—Fatigue—Triamcinolone—hematologic cancer	3.02e-05	0.000199	CcSEcCtD
Cefazolin—Rash—Vincristine—hematologic cancer	3.01e-05	0.000199	CcSEcCtD
Cefazolin—Dermatitis—Vincristine—hematologic cancer	3e-05	0.000198	CcSEcCtD
Cefazolin—Pain—Triamcinolone—hematologic cancer	3e-05	0.000198	CcSEcCtD
Cefazolin—Headache—Vincristine—hematologic cancer	2.99e-05	0.000197	CcSEcCtD
Cefazolin—Loss of consciousness—Prednisone—hematologic cancer	2.98e-05	0.000197	CcSEcCtD
Cefazolin—Hypotension—Dexamethasone—hematologic cancer	2.97e-05	0.000196	CcSEcCtD
Cefazolin—Hypotension—Betamethasone—hematologic cancer	2.97e-05	0.000196	CcSEcCtD
Cefazolin—Nausea—Carmustine—hematologic cancer	2.97e-05	0.000196	CcSEcCtD
Cefazolin—Vomiting—Mitoxantrone—hematologic cancer	2.95e-05	0.000195	CcSEcCtD
Cefazolin—Vomiting—Irinotecan—hematologic cancer	2.95e-05	0.000195	CcSEcCtD
Cefazolin—Nausea—Alitretinoin—hematologic cancer	2.94e-05	0.000194	CcSEcCtD
Cefazolin—Convulsion—Prednisone—hematologic cancer	2.94e-05	0.000194	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—hematologic cancer	2.93e-05	0.000194	CcSEcCtD
Cefazolin—Rash—Irinotecan—hematologic cancer	2.93e-05	0.000193	CcSEcCtD
Cefazolin—Rash—Mitoxantrone—hematologic cancer	2.93e-05	0.000193	CcSEcCtD
Cefazolin—Dermatitis—Irinotecan—hematologic cancer	2.93e-05	0.000193	CcSEcCtD
Cefazolin—Dermatitis—Mitoxantrone—hematologic cancer	2.93e-05	0.000193	CcSEcCtD
Cefazolin—Headache—Mitoxantrone—hematologic cancer	2.91e-05	0.000192	CcSEcCtD
Cefazolin—Headache—Irinotecan—hematologic cancer	2.91e-05	0.000192	CcSEcCtD
Cefazolin—Nausea—Ifosfamide—hematologic cancer	2.91e-05	0.000192	CcSEcCtD
Cefazolin—Feeling abnormal—Triamcinolone—hematologic cancer	2.89e-05	0.000191	CcSEcCtD
Cefazolin—Diarrhoea—Cisplatin—hematologic cancer	2.88e-05	0.00019	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—hematologic cancer	2.88e-05	0.00019	CcSEcCtD
Cefazolin—Vomiting—Gemcitabine—hematologic cancer	2.88e-05	0.00019	CcSEcCtD
Cefazolin—Rash—Gemcitabine—hematologic cancer	2.85e-05	0.000188	CcSEcCtD
Cefazolin—Dermatitis—Gemcitabine—hematologic cancer	2.85e-05	0.000188	CcSEcCtD
Cefazolin—Hypersensitivity—Etoposide—hematologic cancer	2.85e-05	0.000188	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—hematologic cancer	2.83e-05	0.000187	CcSEcCtD
Cefazolin—Headache—Gemcitabine—hematologic cancer	2.83e-05	0.000187	CcSEcCtD
Cefazolin—Nausea—Vincristine—hematologic cancer	2.83e-05	0.000187	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—hematologic cancer	2.82e-05	0.000186	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—hematologic cancer	2.82e-05	0.000186	CcSEcCtD
Cefazolin—Hypersensitivity—Prednisolone—hematologic cancer	2.81e-05	0.000185	CcSEcCtD
Cefazolin—Dyspepsia—Dexamethasone—hematologic cancer	2.8e-05	0.000185	CcSEcCtD
Cefazolin—Dyspepsia—Betamethasone—hematologic cancer	2.8e-05	0.000185	CcSEcCtD
Cefazolin—Urticaria—Triamcinolone—hematologic cancer	2.78e-05	0.000184	CcSEcCtD
Cefazolin—Asthenia—Etoposide—hematologic cancer	2.77e-05	0.000183	CcSEcCtD
Cefazolin—Body temperature increased—Triamcinolone—hematologic cancer	2.77e-05	0.000183	CcSEcCtD
Cefazolin—Anaphylactic shock—Prednisone—hematologic cancer	2.77e-05	0.000183	CcSEcCtD
Cefazolin—Decreased appetite—Betamethasone—hematologic cancer	2.76e-05	0.000182	CcSEcCtD
Cefazolin—Decreased appetite—Dexamethasone—hematologic cancer	2.76e-05	0.000182	CcSEcCtD
Cefazolin—Nausea—Irinotecan—hematologic cancer	2.76e-05	0.000182	CcSEcCtD
Cefazolin—Nausea—Mitoxantrone—hematologic cancer	2.76e-05	0.000182	CcSEcCtD
Cefazolin—Fatigue—Betamethasone—hematologic cancer	2.74e-05	0.000181	CcSEcCtD
Cefazolin—Fatigue—Dexamethasone—hematologic cancer	2.74e-05	0.000181	CcSEcCtD
Cefazolin—Pruritus—Etoposide—hematologic cancer	2.73e-05	0.00018	CcSEcCtD
Cefazolin—Shock—Prednisone—hematologic cancer	2.72e-05	0.00018	CcSEcCtD
Cefazolin—Pain—Dexamethasone—hematologic cancer	2.72e-05	0.000179	CcSEcCtD
Cefazolin—Pain—Betamethasone—hematologic cancer	2.72e-05	0.000179	CcSEcCtD
Cefazolin—Nausea—Gemcitabine—hematologic cancer	2.69e-05	0.000177	CcSEcCtD
Cefazolin—Vomiting—Cisplatin—hematologic cancer	2.68e-05	0.000177	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—hematologic cancer	2.67e-05	0.000176	CcSEcCtD
Cefazolin—Rash—Cisplatin—hematologic cancer	2.66e-05	0.000176	CcSEcCtD
Cefazolin—Dermatitis—Cisplatin—hematologic cancer	2.66e-05	0.000175	CcSEcCtD
Cefazolin—Diarrhoea—Etoposide—hematologic cancer	2.64e-05	0.000175	CcSEcCtD
Cefazolin—Anorexia—Prednisone—hematologic cancer	2.64e-05	0.000174	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—hematologic cancer	2.62e-05	0.000173	CcSEcCtD
Cefazolin—Feeling abnormal—Dexamethasone—hematologic cancer	2.62e-05	0.000173	CcSEcCtD
Cefazolin—Feeling abnormal—Betamethasone—hematologic cancer	2.62e-05	0.000173	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—hematologic cancer	2.61e-05	0.000173	CcSEcCtD
Cefazolin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.6e-05	0.000172	CcSEcCtD
Cefazolin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.6e-05	0.000172	CcSEcCtD
Cefazolin—Hypersensitivity—Triamcinolone—hematologic cancer	2.58e-05	0.00017	CcSEcCtD
Cefazolin—Dizziness—Etoposide—hematologic cancer	2.55e-05	0.000169	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—hematologic cancer	2.54e-05	0.000168	CcSEcCtD
Cefazolin—Urticaria—Betamethasone—hematologic cancer	2.53e-05	0.000167	CcSEcCtD
Cefazolin—Urticaria—Dexamethasone—hematologic cancer	2.53e-05	0.000167	CcSEcCtD
Cefazolin—Dizziness—Prednisolone—hematologic cancer	2.52e-05	0.000166	CcSEcCtD
Cefazolin—Asthenia—Triamcinolone—hematologic cancer	2.51e-05	0.000166	CcSEcCtD
Cefazolin—Abdominal pain—Dexamethasone—hematologic cancer	2.51e-05	0.000166	CcSEcCtD
Cefazolin—Body temperature increased—Dexamethasone—hematologic cancer	2.51e-05	0.000166	CcSEcCtD
Cefazolin—Abdominal pain—Betamethasone—hematologic cancer	2.51e-05	0.000166	CcSEcCtD
Cefazolin—Body temperature increased—Betamethasone—hematologic cancer	2.51e-05	0.000166	CcSEcCtD
Cefazolin—Nausea—Cisplatin—hematologic cancer	2.5e-05	0.000165	CcSEcCtD
Cefazolin—Pruritus—Triamcinolone—hematologic cancer	2.48e-05	0.000164	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—hematologic cancer	2.46e-05	0.000162	CcSEcCtD
Cefazolin—Vomiting—Etoposide—hematologic cancer	2.46e-05	0.000162	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—hematologic cancer	2.45e-05	0.000162	CcSEcCtD
Cefazolin—Agitation—Epirubicin—hematologic cancer	2.44e-05	0.000161	CcSEcCtD
Cefazolin—Dyspepsia—Prednisone—hematologic cancer	2.44e-05	0.000161	CcSEcCtD
Cefazolin—Rash—Etoposide—hematologic cancer	2.44e-05	0.000161	CcSEcCtD
Cefazolin—Dermatitis—Etoposide—hematologic cancer	2.43e-05	0.000161	CcSEcCtD
Cefazolin—Headache—Etoposide—hematologic cancer	2.42e-05	0.00016	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—hematologic cancer	2.42e-05	0.00016	CcSEcCtD
Cefazolin—Decreased appetite—Prednisone—hematologic cancer	2.41e-05	0.000159	CcSEcCtD
Cefazolin—Rash—Prednisolone—hematologic cancer	2.4e-05	0.000159	CcSEcCtD
Cefazolin—Dermatitis—Prednisolone—hematologic cancer	2.4e-05	0.000158	CcSEcCtD
Cefazolin—Fatigue—Prednisone—hematologic cancer	2.39e-05	0.000158	CcSEcCtD
Cefazolin—Headache—Prednisolone—hematologic cancer	2.39e-05	0.000158	CcSEcCtD
Cefazolin—Syncope—Epirubicin—hematologic cancer	2.38e-05	0.000157	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—hematologic cancer	2.37e-05	0.000157	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—hematologic cancer	2.33e-05	0.000154	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—hematologic cancer	2.33e-05	0.000154	CcSEcCtD
Cefazolin—Dizziness—Triamcinolone—hematologic cancer	2.32e-05	0.000153	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—hematologic cancer	2.31e-05	0.000153	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—hematologic cancer	2.3e-05	0.000152	CcSEcCtD
Cefazolin—Nausea—Etoposide—hematologic cancer	2.29e-05	0.000151	CcSEcCtD
Cefazolin—Feeling abnormal—Prednisone—hematologic cancer	2.28e-05	0.000151	CcSEcCtD
Cefazolin—Asthenia—Dexamethasone—hematologic cancer	2.28e-05	0.000151	CcSEcCtD
Cefazolin—Asthenia—Betamethasone—hematologic cancer	2.28e-05	0.000151	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—hematologic cancer	2.27e-05	0.00015	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—hematologic cancer	2.27e-05	0.00015	CcSEcCtD
Cefazolin—Gastrointestinal pain—Prednisone—hematologic cancer	2.26e-05	0.000149	CcSEcCtD
Cefazolin—Nausea—Prednisolone—hematologic cancer	2.26e-05	0.000149	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—hematologic cancer	2.26e-05	0.000149	CcSEcCtD
Cefazolin—Pruritus—Dexamethasone—hematologic cancer	2.25e-05	0.000149	CcSEcCtD
Cefazolin—Pruritus—Betamethasone—hematologic cancer	2.25e-05	0.000149	CcSEcCtD
Cefazolin—Vomiting—Triamcinolone—hematologic cancer	2.23e-05	0.000147	CcSEcCtD
Cefazolin—Rash—Triamcinolone—hematologic cancer	2.21e-05	0.000146	CcSEcCtD
Cefazolin—Dermatitis—Triamcinolone—hematologic cancer	2.21e-05	0.000146	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—hematologic cancer	2.21e-05	0.000146	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—hematologic cancer	2.2e-05	0.000145	CcSEcCtD
Cefazolin—Urticaria—Prednisone—hematologic cancer	2.2e-05	0.000145	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—hematologic cancer	2.2e-05	0.000145	CcSEcCtD
Cefazolin—Headache—Triamcinolone—hematologic cancer	2.19e-05	0.000145	CcSEcCtD
Cefazolin—Body temperature increased—Prednisone—hematologic cancer	2.19e-05	0.000145	CcSEcCtD
Cefazolin—Abdominal pain—Prednisone—hematologic cancer	2.19e-05	0.000145	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—hematologic cancer	2.18e-05	0.000144	CcSEcCtD
Cefazolin—Diarrhoea—Betamethasone—hematologic cancer	2.18e-05	0.000144	CcSEcCtD
Cefazolin—Diarrhoea—Dexamethasone—hematologic cancer	2.18e-05	0.000144	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—hematologic cancer	2.17e-05	0.000143	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—hematologic cancer	2.16e-05	0.000143	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—hematologic cancer	2.16e-05	0.000142	CcSEcCtD
Cefazolin—Shock—Epirubicin—hematologic cancer	2.13e-05	0.000141	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—hematologic cancer	2.13e-05	0.00014	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—hematologic cancer	2.12e-05	0.00014	CcSEcCtD
Cefazolin—Dizziness—Dexamethasone—hematologic cancer	2.1e-05	0.000139	CcSEcCtD
Cefazolin—Dizziness—Betamethasone—hematologic cancer	2.1e-05	0.000139	CcSEcCtD
Cefazolin—Nausea—Triamcinolone—hematologic cancer	2.08e-05	0.000137	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—hematologic cancer	2.06e-05	0.000136	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—hematologic cancer	2.06e-05	0.000136	CcSEcCtD
Cefazolin—Hypersensitivity—Prednisone—hematologic cancer	2.04e-05	0.000135	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—hematologic cancer	2.04e-05	0.000134	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—hematologic cancer	2.02e-05	0.000134	CcSEcCtD
Cefazolin—Vomiting—Dexamethasone—hematologic cancer	2.02e-05	0.000133	CcSEcCtD
Cefazolin—Vomiting—Betamethasone—hematologic cancer	2.02e-05	0.000133	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—hematologic cancer	2.02e-05	0.000133	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—hematologic cancer	2.01e-05	0.000133	CcSEcCtD
Cefazolin—Rash—Betamethasone—hematologic cancer	2e-05	0.000132	CcSEcCtD
Cefazolin—Rash—Dexamethasone—hematologic cancer	2e-05	0.000132	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—hematologic cancer	2e-05	0.000132	CcSEcCtD
Cefazolin—Dermatitis—Betamethasone—hematologic cancer	2e-05	0.000132	CcSEcCtD
Cefazolin—Dermatitis—Dexamethasone—hematologic cancer	2e-05	0.000132	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—hematologic cancer	1.99e-05	0.000132	CcSEcCtD
Cefazolin—Headache—Dexamethasone—hematologic cancer	1.99e-05	0.000131	CcSEcCtD
Cefazolin—Headache—Betamethasone—hematologic cancer	1.99e-05	0.000131	CcSEcCtD
Cefazolin—Asthenia—Prednisone—hematologic cancer	1.99e-05	0.000131	CcSEcCtD
Cefazolin—Pain—Methotrexate—hematologic cancer	1.98e-05	0.000131	CcSEcCtD
Cefazolin—Shock—Doxorubicin—hematologic cancer	1.97e-05	0.00013	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.96e-05	0.00013	CcSEcCtD
Cefazolin—Pruritus—Prednisone—hematologic cancer	1.96e-05	0.000129	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—hematologic cancer	1.92e-05	0.000127	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—hematologic cancer	1.91e-05	0.000126	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—hematologic cancer	1.91e-05	0.000126	CcSEcCtD
Cefazolin—Dyspepsia—Epirubicin—hematologic cancer	1.91e-05	0.000126	CcSEcCtD
Cefazolin—Diarrhoea—Prednisone—hematologic cancer	1.89e-05	0.000125	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.89e-05	0.000125	CcSEcCtD
Cefazolin—Nausea—Dexamethasone—hematologic cancer	1.89e-05	0.000125	CcSEcCtD
Cefazolin—Nausea—Betamethasone—hematologic cancer	1.89e-05	0.000125	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—hematologic cancer	1.88e-05	0.000124	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—hematologic cancer	1.87e-05	0.000124	CcSEcCtD
Cefazolin—Fatigue—Epirubicin—hematologic cancer	1.87e-05	0.000123	CcSEcCtD
Cefazolin—Pain—Epirubicin—hematologic cancer	1.85e-05	0.000122	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—hematologic cancer	1.84e-05	0.000121	CcSEcCtD
Cefazolin—Dizziness—Prednisone—hematologic cancer	1.83e-05	0.000121	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—hematologic cancer	1.83e-05	0.000121	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—hematologic cancer	1.83e-05	0.000121	CcSEcCtD
Cefazolin—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	1.81e-05	0.000568	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNA13—hematologic cancer	1.81e-05	0.000568	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	1.81e-05	0.000568	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.8e-05	0.000563	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ABL1—hematologic cancer	1.79e-05	0.000561	CbGpPWpGaD
Cefazolin—Feeling abnormal—Epirubicin—hematologic cancer	1.78e-05	0.000118	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—hematologic cancer	1.78e-05	0.000118	CcSEcCtD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.77e-05	0.000556	CbGpPWpGaD
Cefazolin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.77e-05	0.000117	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—hematologic cancer	1.76e-05	0.000116	CcSEcCtD
Cefazolin—Vomiting—Prednisone—hematologic cancer	1.76e-05	0.000116	CcSEcCtD
Cefazolin—Rash—Prednisone—hematologic cancer	1.75e-05	0.000115	CcSEcCtD
Cefazolin—TPMT—Metabolism—ABCB1—hematologic cancer	1.74e-05	0.000547	CbGpPWpGaD
Cefazolin—Dermatitis—Prednisone—hematologic cancer	1.74e-05	0.000115	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—hematologic cancer	1.74e-05	0.000115	CcSEcCtD
Cefazolin—Headache—Prednisone—hematologic cancer	1.73e-05	0.000115	CcSEcCtD
Cefazolin—ALB—Hemostasis—ITGAX—hematologic cancer	1.73e-05	0.000542	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—JAK3—hematologic cancer	1.73e-05	0.000542	CbGpPWpGaD
Cefazolin—Fatigue—Doxorubicin—hematologic cancer	1.73e-05	0.000114	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—hematologic cancer	1.72e-05	0.000114	CcSEcCtD
Cefazolin—Pain—Doxorubicin—hematologic cancer	1.71e-05	0.000113	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—hematologic cancer	1.71e-05	0.000113	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—hematologic cancer	1.71e-05	0.000113	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—hematologic cancer	1.7e-05	0.000113	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.7e-05	0.000534	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD9—hematologic cancer	1.7e-05	0.000534	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F3—hematologic cancer	1.7e-05	0.000534	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NCOR1—hematologic cancer	1.69e-05	0.000531	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTM1—hematologic cancer	1.69e-05	0.000531	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.69e-05	0.000529	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.69e-05	0.000529	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.69e-05	0.000529	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HGF—hematologic cancer	1.68e-05	0.000527	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CSF2—hematologic cancer	1.66e-05	0.000521	CbGpPWpGaD
Cefazolin—Asthenia—Methotrexate—hematologic cancer	1.66e-05	0.00011	CcSEcCtD
Cefazolin—ALB—Hemostasis—SELL—hematologic cancer	1.66e-05	0.000519	CbGpPWpGaD
Cefazolin—Feeling abnormal—Doxorubicin—hematologic cancer	1.65e-05	0.000109	CcSEcCtD
Cefazolin—Nausea—Prednisone—hematologic cancer	1.64e-05	0.000109	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.64e-05	0.000108	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—hematologic cancer	1.64e-05	0.000108	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	1.63e-05	0.000512	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	1.63e-05	0.000511	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	1.62e-05	0.000507	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL3RA—hematologic cancer	1.61e-05	0.000506	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.61e-05	0.000504	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—JAK1—hematologic cancer	1.6e-05	0.000503	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PRKCG—hematologic cancer	1.6e-05	0.000503	CbGpPWpGaD
Cefazolin—Hypersensitivity—Epirubicin—hematologic cancer	1.6e-05	0.000105	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—hematologic cancer	1.59e-05	0.000105	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—hematologic cancer	1.58e-05	0.000105	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—hematologic cancer	1.58e-05	0.000105	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—hematologic cancer	1.58e-05	0.000105	CcSEcCtD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.56e-05	0.00049	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.56e-05	0.00049	CbGpPWpGaD
Cefazolin—Asthenia—Epirubicin—hematologic cancer	1.55e-05	0.000103	CcSEcCtD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.55e-05	0.000486	CbGpPWpGaD
Cefazolin—Pruritus—Epirubicin—hematologic cancer	1.53e-05	0.000101	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—hematologic cancer	1.53e-05	0.000101	CcSEcCtD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.52e-05	0.000477	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.52e-05	0.000476	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GMPS—hematologic cancer	1.5e-05	0.000471	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FTCD—hematologic cancer	1.5e-05	0.000471	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PHYH—hematologic cancer	1.5e-05	0.000471	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.5e-05	0.00047	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2RA—hematologic cancer	1.5e-05	0.00047	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—hematologic cancer	1.5e-05	0.000469	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.49e-05	0.000467	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SRC—hematologic cancer	1.49e-05	0.000466	CbGpPWpGaD
Cefazolin—Diarrhoea—Epirubicin—hematologic cancer	1.48e-05	9.78e-05	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—VEGFA—hematologic cancer	1.48e-05	0.000463	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—hematologic cancer	1.48e-05	0.000463	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—H3F3B—hematologic cancer	1.48e-05	0.000463	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FGR—hematologic cancer	1.48e-05	0.000463	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	1.48e-05	0.000463	CbGpPWpGaD
Cefazolin—Hypersensitivity—Doxorubicin—hematologic cancer	1.48e-05	9.75e-05	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—hematologic cancer	1.47e-05	9.71e-05	CcSEcCtD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	1.47e-05	0.000459	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	1.46e-05	0.000457	CbGpPWpGaD
Cefazolin—Rash—Methotrexate—hematologic cancer	1.46e-05	9.63e-05	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—hematologic cancer	1.46e-05	9.62e-05	CcSEcCtD
Cefazolin—Headache—Methotrexate—hematologic cancer	1.45e-05	9.57e-05	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.45e-05	0.000454	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PDGFB—hematologic cancer	1.45e-05	0.000453	CbGpPWpGaD
Cefazolin—Asthenia—Doxorubicin—hematologic cancer	1.44e-05	9.49e-05	CcSEcCtD
Cefazolin—Dizziness—Epirubicin—hematologic cancer	1.43e-05	9.45e-05	CcSEcCtD
Cefazolin—ALB—Hemostasis—MYB—hematologic cancer	1.42e-05	0.000446	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGAL—hematologic cancer	1.42e-05	0.000446	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.42e-05	0.000445	CbGpPWpGaD
Cefazolin—Pruritus—Doxorubicin—hematologic cancer	1.42e-05	9.36e-05	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	1.41e-05	0.000442	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	1.41e-05	0.000442	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	1.41e-05	0.000441	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CDK2—hematologic cancer	1.4e-05	0.00044	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.4e-05	0.00044	CbGpPWpGaD
Cefazolin—Vomiting—Epirubicin—hematologic cancer	1.38e-05	9.09e-05	CcSEcCtD
Cefazolin—ALB—Metabolism—SMPD3—hematologic cancer	1.38e-05	0.000431	CbGpPWpGaD
Cefazolin—Nausea—Methotrexate—hematologic cancer	1.37e-05	9.07e-05	CcSEcCtD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.37e-05	0.00043	CbGpPWpGaD
Cefazolin—Diarrhoea—Doxorubicin—hematologic cancer	1.37e-05	9.05e-05	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.37e-05	0.00043	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.37e-05	0.00043	CbGpPWpGaD
Cefazolin—Rash—Epirubicin—hematologic cancer	1.37e-05	9.01e-05	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—hematologic cancer	1.36e-05	9.01e-05	CcSEcCtD
Cefazolin—Headache—Epirubicin—hematologic cancer	1.36e-05	8.96e-05	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—TGFB1—hematologic cancer	1.36e-05	0.000425	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAC2—hematologic cancer	1.35e-05	0.000423	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK14—hematologic cancer	1.35e-05	0.000422	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.33e-05	0.000418	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.33e-05	0.000417	CbGpPWpGaD
Cefazolin—Dizziness—Doxorubicin—hematologic cancer	1.32e-05	8.75e-05	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	1.32e-05	0.000412	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.31e-05	0.000409	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FN1—hematologic cancer	1.3e-05	0.000409	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—hematologic cancer	1.3e-05	0.000408	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	1.29e-05	0.000405	CbGpPWpGaD
Cefazolin—Nausea—Epirubicin—hematologic cancer	1.29e-05	8.49e-05	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—hematologic cancer	1.28e-05	0.000402	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.28e-05	0.000402	CbGpPWpGaD
Cefazolin—Vomiting—Doxorubicin—hematologic cancer	1.27e-05	8.41e-05	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.27e-05	0.000398	CbGpPWpGaD
Cefazolin—Rash—Doxorubicin—hematologic cancer	1.26e-05	8.34e-05	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—hematologic cancer	1.26e-05	8.33e-05	CcSEcCtD
Cefazolin—TPMT—Metabolism—PIK3CG—hematologic cancer	1.26e-05	0.000394	CbGpPWpGaD
Cefazolin—Headache—Doxorubicin—hematologic cancer	1.26e-05	8.29e-05	CcSEcCtD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.25e-05	0.000392	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—hematologic cancer	1.25e-05	0.000391	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PTPN11—hematologic cancer	1.23e-05	0.000384	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SH2B3—hematologic cancer	1.22e-05	0.000384	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.22e-05	0.000382	CbGpPWpGaD
Cefazolin—ALB—Metabolism—B3GAT1—hematologic cancer	1.2e-05	0.000377	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ASNS—hematologic cancer	1.2e-05	0.000377	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DCK—hematologic cancer	1.2e-05	0.000377	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—hematologic cancer	1.19e-05	0.000374	CbGpPWpGaD
Cefazolin—Nausea—Doxorubicin—hematologic cancer	1.19e-05	7.86e-05	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.18e-05	0.00037	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.18e-05	0.000368	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.17e-05	0.000368	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SPARC—hematologic cancer	1.17e-05	0.000366	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CREBBP—hematologic cancer	1.17e-05	0.000365	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CREBBP—hematologic cancer	1.16e-05	0.000363	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.15e-05	0.000361	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.15e-05	0.000359	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HDC—hematologic cancer	1.14e-05	0.000357	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	1.13e-05	0.000355	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—LCK—hematologic cancer	1.13e-05	0.000354	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.12e-05	0.00035	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.11e-05	0.000348	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—H3F3A—hematologic cancer	1.11e-05	0.000347	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—hematologic cancer	1.11e-05	0.000346	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GATA3—hematologic cancer	1.1e-05	0.000344	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—hematologic cancer	1.1e-05	0.000344	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.1e-05	0.000344	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HSPA5—hematologic cancer	1.09e-05	0.000342	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—hematologic cancer	1.09e-05	0.000342	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.09e-05	0.000341	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—hematologic cancer	1.08e-05	0.00034	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCZ—hematologic cancer	1.08e-05	0.000338	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.06e-05	0.000333	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.05e-05	0.000328	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3R1—hematologic cancer	1.04e-05	0.000327	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CDA—hematologic cancer	1.04e-05	0.000327	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3R1—hematologic cancer	1.04e-05	0.000325	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—JAK2—hematologic cancer	1.01e-05	0.000316	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HDAC2—hematologic cancer	1e-05	0.000315	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PC—hematologic cancer	1e-05	0.000315	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1e-05	0.000314	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD44—hematologic cancer	9.93e-06	0.000311	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGA4—hematologic cancer	9.93e-06	0.000311	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	9.78e-06	0.000307	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GBA—hematologic cancer	9.69e-06	0.000304	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC35B2—hematologic cancer	9.69e-06	0.000304	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	9.69e-06	0.000304	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL3—hematologic cancer	9.68e-06	0.000303	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	9.64e-06	0.000302	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—hematologic cancer	9.63e-06	0.000302	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA1—hematologic cancer	9.62e-06	0.000301	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—hematologic cancer	9.57e-06	0.0003	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PTPN1—hematologic cancer	9.52e-06	0.000298	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	9.47e-06	0.000297	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—hematologic cancer	9.38e-06	0.000294	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RASGRP1—hematologic cancer	9.36e-06	0.000293	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SYK—hematologic cancer	9.33e-06	0.000293	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	9.24e-06	0.00029	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	9.1e-06	0.000285	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA2—hematologic cancer	8.95e-06	0.00028	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTAP—hematologic cancer	8.87e-06	0.000278	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	8.84e-06	0.000277	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—hematologic cancer	8.79e-06	0.000275	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.72e-06	0.000273	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GRB2—hematologic cancer	8.42e-06	0.000264	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PDGFA—hematologic cancer	8.4e-06	0.000263	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	8.4e-06	0.000263	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTEN—hematologic cancer	8.33e-06	0.000261	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	8.17e-06	0.000256	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	8.13e-06	0.000255	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ABL1—hematologic cancer	8.09e-06	0.000254	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—EP300—hematologic cancer	7.94e-06	0.000249	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FHL2—hematologic cancer	7.9e-06	0.000248	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EP300—hematologic cancer	7.88e-06	0.000247	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AGRN—hematologic cancer	7.75e-06	0.000243	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	7.71e-06	0.000242	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SRC—hematologic cancer	7.67e-06	0.00024	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HGF—hematologic cancer	7.61e-06	0.000238	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CSF2—hematologic cancer	7.52e-06	0.000236	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—hematologic cancer	7.47e-06	0.000234	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NRAS—hematologic cancer	7.38e-06	0.000231	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH2—hematologic cancer	7.35e-06	0.00023	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMMR—hematologic cancer	7.35e-06	0.00023	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCG—hematologic cancer	7.26e-06	0.000228	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—JAK1—hematologic cancer	7.26e-06	0.000228	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK3—hematologic cancer	7.06e-06	0.000221	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.93e-06	0.000217	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ARNTL—hematologic cancer	6.91e-06	0.000216	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—hematologic cancer	6.85e-06	0.000215	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.79e-06	0.000213	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2RA—hematologic cancer	6.78e-06	0.000213	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	6.73e-06	0.000211	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACP5—hematologic cancer	6.72e-06	0.000211	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CA9—hematologic cancer	6.72e-06	0.000211	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOR2—hematologic cancer	6.63e-06	0.000208	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	6.56e-06	0.000205	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PDGFB—hematologic cancer	6.55e-06	0.000205	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CDK2—hematologic cancer	6.35e-06	0.000199	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—hematologic cancer	6.35e-06	0.000199	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH1—hematologic cancer	6.32e-06	0.000198	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCC3—hematologic cancer	6.25e-06	0.000196	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTO1—hematologic cancer	6.25e-06	0.000196	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TXN—hematologic cancer	6.25e-06	0.000196	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	6.2e-06	0.000194	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SPHK1—hematologic cancer	6.11e-06	0.000192	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK14—hematologic cancer	6.09e-06	0.000191	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	6.02e-06	0.000189	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FN1—hematologic cancer	5.9e-06	0.000185	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—hematologic cancer	5.87e-06	0.000184	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UGT1A1—hematologic cancer	5.87e-06	0.000184	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—hematologic cancer	5.83e-06	0.000183	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC22A1—hematologic cancer	5.71e-06	0.000179	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CRABP1—hematologic cancer	5.71e-06	0.000179	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—hematologic cancer	5.65e-06	0.000177	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—hematologic cancer	5.64e-06	0.000177	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALOX5—hematologic cancer	5.57e-06	0.000174	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PTPN11—hematologic cancer	5.55e-06	0.000174	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—hematologic cancer	5.4e-06	0.000169	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NUP98—hematologic cancer	5.39e-06	0.000169	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CREBBP—hematologic cancer	5.24e-06	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADCY7—hematologic cancer	5.23e-06	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA3—hematologic cancer	5.23e-06	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NUP214—hematologic cancer	5.2e-06	0.000163	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.14e-06	0.000161	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	5.12e-06	0.00016	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTR—hematologic cancer	5.09e-06	0.00016	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCG2—hematologic cancer	5.09e-06	0.00016	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO2—hematologic cancer	4.99e-06	0.000157	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—hematologic cancer	4.97e-06	0.000156	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—hematologic cancer	4.84e-06	0.000152	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—hematologic cancer	4.8e-06	0.00015	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.77e-06	0.000149	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—hematologic cancer	4.76e-06	0.000149	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SDC1—hematologic cancer	4.73e-06	0.000148	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3R1—hematologic cancer	4.69e-06	0.000147	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—JAK2—hematologic cancer	4.56e-06	0.000143	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.53e-06	0.000142	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.52e-06	0.000142	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—hematologic cancer	4.33e-06	0.000136	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.27e-06	0.000134	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.18e-06	0.000131	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NQO1—hematologic cancer	4.03e-06	0.000126	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CD44—hematologic cancer	4.03e-06	0.000126	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—hematologic cancer	3.98e-06	0.000125	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.94e-06	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYCS—hematologic cancer	3.81e-06	0.000119	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSP90AA1—hematologic cancer	3.78e-06	0.000119	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EP300—hematologic cancer	3.57e-06	0.000112	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SRC—hematologic cancer	3.47e-06	0.000109	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.41e-06	0.000107	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—hematologic cancer	3.38e-06	0.000106	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—hematologic cancer	3.36e-06	0.000105	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NRAS—hematologic cancer	3.34e-06	0.000105	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.25e-06	0.000102	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK3—hematologic cancer	3.2e-06	0.0001	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCB1—hematologic cancer	3.18e-06	9.96e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—hematologic cancer	3.1e-06	9.72e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOR1—hematologic cancer	3.09e-06	9.67e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—hematologic cancer	3.09e-06	9.67e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—hematologic cancer	2.87e-06	9e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—hematologic cancer	2.73e-06	8.55e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—hematologic cancer	2.64e-06	8.27e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—hematologic cancer	2.55e-06	8e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—hematologic cancer	2.44e-06	7.65e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.4e-06	7.53e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—hematologic cancer	2.29e-06	7.18e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—hematologic cancer	2.16e-06	6.76e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CREBBP—hematologic cancer	2.12e-06	6.66e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—hematologic cancer	2.01e-06	6.31e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3R1—hematologic cancer	1.9e-06	5.96e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—hematologic cancer	1.76e-06	5.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTEN—hematologic cancer	1.52e-06	4.75e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—EP300—hematologic cancer	1.45e-06	4.53e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—hematologic cancer	1.07e-06	3.35e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—hematologic cancer	8.74e-07	2.74e-05	CbGpPWpGaD
